Nikki Hastings
Director/Board Member at Virginia Biotechnology Association
Profile
Nikki Hastings is on the board of Virginia Biotechnology Association.
Nikki Hastings is an operations biotech executive and entrepreneurial ecosystem builder with over 15 years of experience with early-stage biotech/medtech and medical device companies.
She has held executive management roles at companies across multiple industry sectors including HemoShear Therapeutics, Contraline, and Cerillo
Nikki Hastings active positions
| Companies | Position | Start |
|---|---|---|
Virginia Biotechnology Association
 Virginia Biotechnology Association Miscellaneous Commercial ServicesCommercial Services Virginia Biotechnology Association promotes the biotechnology industry. The private company is based in Richmond, VA. The company was founded in 1992 by Terry R. Woodworth. John L. Newby has been the CEO of the company since 2019. | Director/Board Member | 2022-03-31 |
| McIntire School of Commerce | Director/Board Member | - |
Former positions of Nikki Hastings
| Companies | Position | End |
|---|---|---|
CAV Angels /Venture Capital/
 CAV Angels /Venture Capital/ Investment ManagersFinance CAV Angels /Venture Capital/ (CAV Angels) is a venture capital subsidiary of CAV Angels Investments LLC founded in 2015 by Jim Cheng, Rich Diemer, and Dick Crawford. The firm is headquartered in Charlottesville, Virginia. | Director/Board Member | 2021-07-31 |
Contraline, Inc.
 Contraline, Inc. BiotechnologyHealth Technology Contraline, Inc. is a medical device company, which engages in the development of novel hydrogels for reproductive and contraceptive applications. Its Echo-VR product applies hydrogel technology to physically block sperm within the male reproductive tract. The company was founded by Kevin Eisenfrats and John C. Herr in 2015 and is headquartered in Charlottesville, VA. | Chief Operating Officer | 2018-10-30 |
HemoShear Therapeutics, Inc.
 HemoShear Therapeutics, Inc. Medical/Nursing ServicesHealth Services HemoShear Therapeutics LLC engages in the development of human-relevant systems for applications in drug research and development. It creates human relevant systems that replicate the biology of organ systems and diseases throughout drug discovery and development. The firm's technology imposes human-derived hemodynamic forces on human primary cells to recreate human biology. The company was founded by Brian R. Wamhoff and Brett R. Blackman in 2008 and is headquartered in Charlottesville, VA. | Director/Board Member | 2011-02-27 |
Training of Nikki Hastings
| University of Virginia | Doctorate Degree |
| North Carolina State University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 4 |
|---|---|
Virginia Biotechnology Association
Virginia Biotechnology Association Miscellaneous Commercial ServicesCommercial Services Virginia Biotechnology Association promotes the biotechnology industry. The private company is based in Richmond, VA. The company was founded in 1992 by Terry R. Woodworth. John L. Newby has been the CEO of the company since 2019. | Commercial Services |
CAV Angels /Venture Capital/
CAV Angels /Venture Capital/ Investment ManagersFinance CAV Angels /Venture Capital/ (CAV Angels) is a venture capital subsidiary of CAV Angels Investments LLC founded in 2015 by Jim Cheng, Rich Diemer, and Dick Crawford. The firm is headquartered in Charlottesville, Virginia. | Finance |
Contraline, Inc.
Contraline, Inc. BiotechnologyHealth Technology Contraline, Inc. is a medical device company, which engages in the development of novel hydrogels for reproductive and contraceptive applications. Its Echo-VR product applies hydrogel technology to physically block sperm within the male reproductive tract. The company was founded by Kevin Eisenfrats and John C. Herr in 2015 and is headquartered in Charlottesville, VA. | Health Technology |
HemoShear Therapeutics, Inc.
HemoShear Therapeutics, Inc. Medical/Nursing ServicesHealth Services HemoShear Therapeutics LLC engages in the development of human-relevant systems for applications in drug research and development. It creates human relevant systems that replicate the biology of organ systems and diseases throughout drug discovery and development. The firm's technology imposes human-derived hemodynamic forces on human primary cells to recreate human biology. The company was founded by Brian R. Wamhoff and Brett R. Blackman in 2008 and is headquartered in Charlottesville, VA. | Health Services |
- Stock Market
- Insiders
- Nikki Hastings
